About: Tapentadol extended release for chronic pain patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Tapentadol extended release for chronic pain patients Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 15 January 2013

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articol științific (ro) articolo scientifico (it) artigo científico (gl) artigo científico (pt) artigo científico (pt-br) artikull shkencor (sq) artículo científico (es) bilimsel makale (tr) scienca artikolo (eo) vedecký článok (sk) vetenskaplig artikel (sv) vitenskapelig artikkel (nb) vitskapeleg artikkel (nn) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научная статья (ru) научни чланак (sr) מאמר מדעי (he) artikel ilmiah (id) article scientifique (fr) বৈজ্ঞানিক নিবন্ধ (bn) artículu científicu espublizáu en 2013 (ast) наукова стаття, опублікована в січні 2013 (uk) scientific article published on 15 January 2013 (en) scientific article published on 15 January 2013 (en-ca) scientific article published on 15 January 2013 (en-gb) مقالة علمية نشرت في 15 يناير 2013 (ar)
publication date	wds:Q38074832-898D3212-2E54-4754-BAAE-1F846AC1E079
publication date	2013-01-15 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q38074832-DD979DE7-F545-4505-A558-C46B41664BED
language of work or name	English
exact match	wds:Q38074832-91C02D97-47BF-4ED8-8E54-67E832EE650E
exact match	https://scigraph.springernature.com/pub.10.1007/s12325-013-0002-y
cites work	wds:Q38074832-03D588C8-F8F7-4F9D-8B05-AF667649461E wds:Q38074832-0693A2C0-1BC9-4409-92F3-D4CC27964A18 wds:Q38074832-0D874CF8-0807-466C-8CA6-117EC8CF4138 wds:Q38074832-143323C2-E7E6-4448-BF44-C0E0C89C13AC wds:Q38074832-1A6B87CE-970D-4FFD-9564-229EF6A0E1F6 wds:Q38074832-1BF03FA9-913D-4F71-92B5-B3668CE14484 wds:Q38074832-26DDF164-7675-4EDC-865A-A1A9DA9A544E wds:Q38074832-346CB444-5402-4A34-93C3-EDCFFA44885D wds:Q38074832-417462FA-5579-43F8-A323-D4F0D1CF22CF wds:Q38074832-48759485-52D5-45DD-B7C4-B9078EFBC113 wds:Q38074832-54726224-85F3-4CBE-AD6E-275EDA4DCD49 wds:Q38074832-54CA0DA5-5723-406B-96A5-6B3D283A08ED wds:Q38074832-5D660906-445C-4F6F-B654-DF48FE5346F6 wds:Q38074832-5F85ED9D-ACF8-4E67-A995-FCAA6D66C579 wds:Q38074832-5FD5750F-1EB5-45FD-9620-ACF3434C1B43 wds:Q38074832-60A2CA25-B68D-47E8-99C7-7769B9D4A33B wds:Q38074832-6B781BF4-5D75-4755-AD89-A97068537FBC wds:Q38074832-6DAFCFEC-2449-4E4D-9291-38E2A889DF8F wds:Q38074832-793DB7B6-06C1-480C-993F-B534BF3957FF wds:Q38074832-7F9BE694-D690-4E0C-B2EF-5FB1E29D1B2A wds:Q38074832-82CAEAE7-5B25-482A-B5E9-38CFD4CF5CD8 wds:Q38074832-84E2BCCF-3B39-496B-9C6C-8CC30E3171AE wds:Q38074832-87BB3F25-04B8-4E32-A8A6-A97FDA9F0D90 wds:Q38074832-9FCFE821-033B-4653-94B3-75CCC877CD52 wds:Q38074832-A3CABA72-A72F-4B32-A11A-C09D612147A3 wds:Q38074832-ABA577EF-8C08-4C1F-8C9E-C8BE8FA7C95D wds:Q38074832-AE54D73B-A335-4DCA-BB9A-7002DA976FB0 wds:Q38074832-B1C01383-0B16-4039-BFED-8748CEE0C094 wds:Q38074832-C434BFA6-95B9-4A0B-B656-37DA139D6730 wds:Q38074832-CC78F16F-202B-4CFA-83D0-47AD6F821EB2 wds:Q38074832-CD7ED576-C27F-4D6B-8082-651319A6D26F wds:Q38074832-D074A9C2-4A48-4E0B-8490-5869D468D882 wds:Q38074832-D6F31AA0-55A3-40D0-886F-E994DCE1BD99 wds:Q38074832-D94C6351-EE07-402A-8ED6-CC2EF2F5E254 wds:Q38074832-E4475F07-7FD0-405F-8B6C-9A54D4864E4B wds:Q38074832-ED6D319F-D6E6-4EF7-AE01-71C3F95390FE wds:Q38074832-F0F8571D-1750-4331-9FF7-F442FE257BAB wds:Q38074832-F29B6842-508E-4DB0-AC65-9DBF70CA92DA wds:Q38074832-F39EA73D-8757-4BBD-A80F-43914D18C97A
cites work	Pathophysiology of pain Patient safety is not enough: targeting quality improvements to optimize the health of the population Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain Efficacy and safety of Tapentadol extended release compared with oxycodone controlled release for the management of moderate to severe chronic pain related to osteoarthritis of the knee: a randomized, double-blind, placebo- and active-controlled pha A systematic review on the effectiveness of pharmacological interventions for chronic non-specific low-back pain EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision Systematic review and meta-analysis of randomized controlled trials of cognitive behaviour therapy and behaviour therapy for chronic pain in adults, excluding headache Meta-analysis: acupuncture for low back pain Acupuncture and dry-needling for low back pain: an updated systematic review within the framework of the cochrane collaboration. Meta-analysis of psychological interventions for chronic low back pain The economic burden of back pain in the UK. Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base A systematic review of paracetamol for non-specific low back pain Psychological interventions for arthritis pain management in adults: a meta-analysis Long-term use of acetaminophen, aspirin, and other nonsteroidal anti-inflammatory drugs and risk of hematologic malignancies: results from the prospective Vitamins and Lifestyle (VITAL) study Cancer risk associated with long-term use of acetaminophen in the prospective VITamins and lifestyle (VITAL) study Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce Recommendations for the pharmacological management of neuropathic pain: an overview and literature update Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study. Socio-economic burden of patients with a diagnosis related to chronic pain--register data of 840,000 Swedish patients (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software